2025-07-19 - Analysis Report
Okay, here's an analysis of Procter & Gamble (PG) based on the provided data, formatted for a report and including key financial information.

## Procter & Gamble (PG) Stock Analysis

**Ticker:** PG
**Company:** Procter & Gamble Co.
**Description:** Procter & Gamble is a multinational consumer goods corporation that provides branded consumer packaged goods.

### 1. Performance vs. S&P 500 (VOO)

**Key Numbers:**

*   PG Cumulative Return: 48.34%
*   VOO (S&P 500) Cumulative Return: 96.72%
*   Return Disparity: -48.38%
*   Disparity Range: Max 29.9, Min -49.3, Current -48.8
*   Relative Disparity: 0.6

**Analysis:**

PG has significantly underperformed the S&P 500 (VOO) over the period analyzed.  The return disparity is quite large at -48.38%. A relative disparity of 0.6 indicates that the current underperformance is near the lowest end of its historical range relative to the S&P 500.

**Alpha/Beta Analysis Table:**

| Year       | CAGR     | MDD    | Alpha   | Beta   | Cap(B) |
|------------|----------|--------|---------|--------|--------|
| 2015-2017  | 21.0%   | 7.9%   | -8.0%   | 0.0    | 215.4  |
| 2016-2018  | 5.0%   | 56.7%  | -13.0%  | 0.1    | 215.5  |
| 2017-2019  | 30.0%   | 56.7%  | 0.0%    | 0.5    | 292.8  |
| 2018-2020  | 38.0%   | 59.1%  | 18.0%   | 0.3    | 326.2  |
| 2019-2021  | 56.0%   | 59.1%  | 8.0%    | 0.3    | 383.5  |
| 2020-2022  | 24.0%   | 74.7%  | 22.0%   | 0.3    | 355.3  |
| 2021-2023  | 30.0%   | 74.7%  | 12.0%   | 0.3    | 343.6  |
| 2022-2024  | 8.0%   | 74.7%  | -17.0%  | 0.3    | 393.1  |
| 2023-2025  | -11.0%  | 71.6%  | -60.0%  | 0.2    | 363.6  |

**Analysis of Table:**

*   **CAGR:** Fluctuates significantly, ranging from -11% to 56%. The most recent period shows a negative CAGR.
*   **MDD:** Maximum Drawdown is high, indicating substantial potential losses during specific periods.
*   **Alpha:**  Alpha values vary considerably. Negative alpha suggests underperformance relative to the market.  The most recent period has a very negative alpha.
*   **Beta:** Beta values are relatively low, indicating lower volatility than the overall market.
*   **Cap:** Market Cap is increasing over time.

### 2. Recent Stock Price Movements

**Key Numbers:**

*   Current Price: 155.10
*   Previous Close: 154.56
*   Price Change: 0.35
*   5-day Moving Average: 154.18
*   20-day Moving Average: 158.08
*   60-day Moving Average: 161.14

**Analysis:**

The current price is slightly higher than the previous close, indicating a minor increase. The 5-day moving average is below the 20-day and 60-day moving averages, suggesting a potential short-term downward trend.

### 3. Market Risk Indicators and Expected Return

**Key Numbers:**

*   Market Risk Indicator (MRI): 0.34 (Low Risk)
*   RSI: 36.95
*   PPO: -0.20
*   Hybrid Signal: Cash_1%_Buy 80% of cash (27 shares - Caution - MRI:0.34)
*   Recent (20-day) Relative Disparity Change: 0.6 (Positive - Short-term increase)
*   Expected Return: 788.2%

**Analysis:**

*   **MRI:** The MRI of 0.34 suggests a low-risk environment.
*   **RSI:** An RSI of 36.95 is below 50, suggesting a possibility of an upward correction(RSI is not in overbought or oversold teritory).
*   **PPO:** A negative PPO (-0.20) indicates that the short-term moving average is below the long-term moving average, which can be a bearish signal.
*   **Hybrid Signal:** The hybrid signal suggests a cautious approach, recommending a modest cash allocation and buying some shares.
*   **Price Change Impact:** The small price change of 0.35 doesn't indicate any significant market event.
*   **Expected Return:** The very high expected return (788.2%) should be taken with caution. It represents a potential long-term excess return over the S&P 500 if a dollar-cost averaging strategy is used.

### 4. Recent News & Significant Events

*   **[2025-07-17]:** Major business developments, regulatory changes, or market events are impacting Procter & Gamble.
*   **[2025-07-15]:** Analysts are discussing the company's performance in the context of industry trends and global economic factors.
*   **[2025-07-19]:** The stock has shown notable volatility.
*   **[2025-07-16]:** Market experts highlight both risks and opportunities.

**Analysis:**

Recent news suggests the stock is experiencing volatility and is subject to market scrutiny. Investors should monitor company announcements and news closely.

### 5. Recent Earnings Analysis

| Date       | EPS  | Revenue      |
|------------|------|--------------|
| 2025-04-24 | 1.58 | 19.78 B$     |
| 2025-01-22 | 1.94 | 21.88 B$     |
| 2024-10-18 | 1.65 | 21.74 B$     |
| 2024-04-19 | 1.56 | 20.20 B$     |
| 2025-04-24 | 1.56 | 20.20 B$     |

**Analysis:**

The provided earnings data shows fluctuating EPS and revenue. There seems to be a recent dip in both EPS and revenue. More consecutive quarters of data would provide a clearer trend.

### 6. Financial Information

**Revenue and Profitability:**

| Quarter      | Revenue    | Profit Margin |
|--------------|------------|---------------|
| 2025-03-31   | $19.78B    | 50.98%        |
| 2024-12-31   | $21.88B    | 52.39%        |
| 2024-09-30   | $21.74B    | 52.06%        |
| 2024-06-30   | $20.53B    | 49.60%        |
| 2024-03-31   | $20.20B    | 51.20%        |

**Capital and Profitability:**

| Quarter      | Equity     | ROE    |
|--------------|------------|--------|
| 2025-03-31   | $52.27B    | 7.21%  |
| 2024-12-31   | $51.17B    | 9.05%  |
| 2024-09-30   | $51.84B    | 7.64%  |
| 2024-06-30   | $50.29B    | 6.24%  |
| 2024-03-31   | $50.06B    | 7.50%  |

**Analysis:**

*   **Revenue:** Quarterly revenue fluctuates, with a recent decline.
*   **Profit Margin:** Profit margins are generally high, indicating strong operational efficiency. There is a slight decrease in the latest quarter.
*   **Equity:** Total equity is gradually increasing.
*   **ROE:** Return on Equity shows some variability.

### 7. Overall Summary and Recommendations

**Summary:**

Procter & Gamble (PG) has significantly underperformed the S&P 500 in the analyzed period. While the MRI indicates a low-risk environment, other indicators like negative PPO and recent earnings results suggest caution. The company is experiencing volatility and is subject to market scrutiny. The very high "Expected Return" should be carefully scrutinized, as it is a long-term estimate and might not reflect near-term performance.

**Recommendations:**

*   **Cautious Approach:** Given the underperformance and mixed signals, a cautious approach is warranted.
*   **Monitor News:** Pay close attention to company announcements, regulatory changes, and market events.
*   **Further Research:** Conduct further research into the reasons for the recent underperformance, particularly regarding the negative alpha and earnings trends.
*   **Consider Diversification:** Ensure your portfolio is well-diversified to mitigate risks associated with individual stock performance.
*   **Long-Term Perspective:** While the "Expected Return" is high, consider a long-term investment horizon and dollar-cost averaging if pursuing this stock.
